Occurrence of cytotoxic 9-oxononanoyl secosterol aldehydes in human low-density lipoprotein

Free Radical Biology and Medicine

Volumn 60, Issue , 2013, Pages 73-79

  Miyoshi, Noriyuki ^a   Iwasaki, Nozomi ^a   Tomono, Susumu ^a   Higashi, Tatsuya ^b   Ohshima, Hiroshi ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

Cholesteryl ester; Cytotoxicity; Free radicals; LC ESI MS MS; LDL; Secosterol

Indexed keywords

ALDEHYDE DERIVATIVE; CHOLESTEROL ESTER; LOW DENSITY LIPOPROTEIN;

ARTICLE; CELL VIABILITY; CYTOTOXICITY; FEMALE; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; LIMIT OF DETECTION; MALE; NORMAL HUMAN; OZONATION; OZONOLYSIS; PRIORITY JOURNAL;

ALDEHYDES; CELL PROLIFERATION; CHOLESTANONES; CHOLESTEROL; CHOLESTEROL ESTERS; HL-60 CELLS; HUMANS; LEUKEMIA; LIPOPROTEINS, LDL; OXIDATION-REDUCTION; OZONE; SECOSTEROIDS;

EID: 84874932236     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2013.01.029     Document Type: Article

References (29)

1. D. Steinberg, S. Parthasarathy, T.E. Carew, J.C. Khoo, and J.L. Witztum Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity N. Engl. J. Med. 320 1989 915 924
2. N. Leitinger Cholesteryl ester oxidation products in atherosclerosis Mol. Aspects Med. 24 2003 239 250
3. A.J. Brown, and W. Jessup Oxysterols: sources, cellular storage and metabolism, and new insights into their roles in cholesterol homeostasis Mol. Aspects Med. 30 2009 111 122
4. J. Gumulka, and L.L. Smith Ozonization of cholesterol J. Am. Chem. Soc. 105 1983 1972 1979
5. K. Jaworski, and L.L. Smith Ozonization of cholesterol in nonparticipating solvents J. Org. Chem. 53 1988 545 554
6. Z. Paryzek, J. Martynow, and W. Swoboda The reaction of cholesterol with ozone and alcohols: a revised mechanism and structure of the principal product J. Chem. Soc. Perkin Trans 1 1990 1222 1223
7. P.J. Wentworth, J. Nieva, C. Takeuchi, R. Galve, A.D. Wentworth, R.B. Dilley, G.A. DeLaria, A. Saven, B.M. Babior, K.D. Janda, A. Eschenmoser, and R.A. Lerner Evidence for ozone formation in human atherosclerotic arteries Science 302 2003 1053 1056
8. J. Bieschke, Q. Zhang, D.A. Bosco, R.A. Lerner, E.T. Powers, P.J. Wentworth, and J.W. Kelly Small molecule oxidation products trigger disease-associated protein misfolding Acc. Chem. Res. 39 2006 611 619
9. D.A. Bosco, D.M. Fowler, Q. Zhang, J. Nieva, E.T. Powers, P.J. Wentworth, R.A. Lerner, and J.W. Kelly Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate alpha-synuclein fibrilization Nat. Chem. Biol. 2 2006 249 253
10. K. Sathishkumar, M. Haque, T.E. Perumal, J. Francis, and R.M. Uppu A major ozonation product of cholesterol, 3β-hydroxy-5-oxo-5,6-secocholestan- 6-al, induces apoptosis in H9c2 cardiomyoblasts FEBS Lett. 579 2005 6444 6450
11. K. Sathishkumar, S.N. Murthy, and R.M. Uppu Cytotoxic effects of oxysterols produced during ozonolysis of cholesterol in murine GT1-7 hypothalamic neurons Free Radic. Res. 41 2007 82 88
12. K. Sathishkumar, X. Gao, A.C. Raghavamenon, N. Parinandi, W.A. Pryor, and R.M. Uppu Cholesterol secoaldehyde induces apoptosis in H9c2 cardiomyoblasts through reactive oxygen species involving mitochondrial and death receptor pathways Free Radic. Biol. Med. 47 2009 548 558
13. Q. Zhang, E.T. Powers, J. Nieva, M.E. Huff, M.A. Dendle, J. Bieschke, C.G. Glabe, A. Eschenmoser, P.J. Wentworth, R.A. Lerner, and J.W. Kelly Metabolite-initiated protein misfolding may trigger Alzheimer's disease Proc. Natl. Acad. Sci. USA 101 2004 4752 4757
14. J. Bieschke, Q. Zhang, E.T. Powers, R.A. Lerner, and J.W. Kelly Oxidative metabolites accelerate Alzheimer's amyloidogenesis by a two-step mechanism, eliminating the requirement for nucleation Biochemistry 44 2005 4977 4983
15. J. Nieva, B.D. Song, J.K. Rogel, D. Kujawara, L. Altobel, A. Izharrudin, G.E. Boldt, R.K. Grover, A.D. Wentworth, and P.J. Wentworth Cholesterol secosterol aldehydes induce amyloidogenesis and dysfunction of wild-type tumor protein p53 Chem. Biol. 18 2011 920 927
16. S. Tomono, N. Miyoshi, H. Shiokawa, T. Iwabuchi, Y. Aratani, T. Higashi, H. Nukaya, and H. Ohshima Formation of cholesterol ozonolysis products in vitro and in vivo through a myeloperoxidase-dependent pathway J. Lipid Res. 52 2011 87 97
17. Y.L. Lai, S. Tomono, N. Miyoshi, and H. Ohshima Inhibition of endothelial- and neuronal-type, but not inducible-type, nitric oxide synthase by the oxidized cholesterol metabolite secosterol aldehyde: implications for vascular and neurodegenerative diseases J. Clin. Biochem. Nutr. 50 2012 84 89
18. J. Siedel, E.O. Hägele, J. Ziegenhorn, and A.W. Wahlefeld Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency Clin. Chem. 29 1983 1075 1080
19. S. Tomono, N. Miyoshi, M. Ito, T. Higashi, and H. Ohshima A highly sensitive LC-ESI-MS/MS method for the quantification of cholesterol ozonolysis products secosterol-A and secosterol-B after derivatization with 2-hydrazino-1-methylpyridine J. Chromatogr. B Anal. Technol. Biomed. Life Sci 879 2011 2802 2808
20. Y. Kawai, A. Saito, N. Shibata, M. Kobayashi, S. Yamada, T. Osawa, and K. Uchida Covalent binding of oxidized cholesteryl esters to protein: implications for oxidative modification of low density lipoprotein and atherosclerosis J. Biol. Chem. 278 2003 21040 21049
21. 2-chloride system Biochem. Biophys. Res. Commun. 383 2009 222 227
22. J. Brinkhorst, S.J. Nara, and D.A. Pratt Hock cleavage of cholesterol 5α-hydroperoxide: an ozone-free pathway to the cholesterol ozonolysis products identified in arterial plaque and brain tissue J. Am. Chem. Soc 130 2008 12224 12225
23. g)] as well as ozone with cholesterol Chem. Res. Toxicol. 22 2009 875 884
24. A.D. Wentworth, B.D. Song, J. Nieva, A. Shafton, S. Tripurenani, and P.J. Wentworth The ratio of cholesterol 5,6-secosterols formed from ozone and singlet oxygen offers insight into the oxidation of cholesterol in vivo Chem. Commun. (Cambridge) 21 2009 3098 3100
25. C. Takeuchi, R. Galve, J. Nieva, D.P. Witter, A.D. Wentworth, R.P. Troseth, R.A. Lerner, and P.J. Wentworth Proatherogenic effects of the cholesterol ozonolysis products, atheronal-A and atheronal-B Biochemistry 45 2006 7162 7170
26. C.R. Stewart, L.M. Wilson, Q. Zhang, C.L. Pham, L.J. Waddington, M.K. Staples, D. Stapleton, J.W. Kelly, and G.J. Howlett Oxidized cholesterol metabolites found in human atherosclerotic lesions promote apolipoprotein C-II amyloid fibril formation Biochemistry 46 2007 5552 5561
27. J. Nieva, A. Shafton, L.J. Altobell, S. Tripuraneni, J.K. Rogel, A.D. Wentworth, R.A. Lerner, and P.J. Wentworth Lipid-derived aldehydes accelerate light chain amyloid and amorphous aggregation Biochemistry 47 2008 7695 7705
28. N.K. Cygan, J.C. Scheinost, T.D. Butters, and P.J. Wentworth Adduction of cholesterol 5,6-secosterol aldehyde to membrane-bound myelin basic protein exposes an immunodominant epitope Biochemistry 50 2011 2092 2100
29. Tomono, S.; Yasue, Y.; Miyoshi, N.; Ohshima, H. Cytotoxic effects of secosterols and their derivatives on several cultured cells. Biosci. Biotechnol. Biochem. (in press).